Source: International Congress 2019 – Tuberculosis epidemiology, bronchiectasis, other infections and spirometry
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. Verma (Lucknow, India), A. Gupta (Lucknow, India), A. Singh (Lucknow, India), S. Kant (Lucknow, India), R. Kushwaha (Lucknow, India), U. Verma (Lucknow, India), H. Kumar (Lucknow, India), A. Pandey (Lucknow, India). Pattern of Periodontal diseases in Hospitalized Patients with Non-Tubercular Respiratory diseases. 2794

Member's Comments

No comment yet.

Related content which might interest you: “A Study of Infective Etiology in Patients With Acute Exacerbation of COPD” Source: International Congress 2019 – Airway infection in COPD Year: 2019 PES Pathogens in Elderly Patients with Acquired Pneumonia in the Community Source: Virtual Congress 2020 – Clinical challenges in pneumonia Year: 2020 O'Donnell Criteria as a Score of Bad Prognosis in Hospitalized Patients with Acute Exacerbation of Non-Cystic Fibrosis Bronchiectasis, an Observetional Study Source: Virtual Congress 2021 – Bronchiectasis Year: 2021 Predictors of exacerbations in patients with bronchiectasis Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014 Microbiota in children with HIV-associated bronchiectasis Source: International Congress 2016 – Paediatric respiratory infection and immunology Year: 2016 The Impact of Multimorbidity on Hospitalizations in Patients with Chronic Obstructive Pulmonary Disease (COPD): a Population-Based Study Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019 Medication Effect on Acute Exacerbation and Mortality in Patients with Coexistent COPD and GERD Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 Blood Eosinophils and Outcomes in Severe Hospitalized Exacerbations of COPD. Source: International Congress 2017 – COPD biomarkers Year: 2017 Respiratory diseases and COVID-19 Source: ERS Course 2021 - COVID-19: State of the art Year: 2021 Respiratory diseases Source: ERS Online Course 2016 Year: 2016 The Effects Of Respiratory Viruses on The Acute Pulmonary Exacerbations In Cystic Fibrosis Patients Source: International Congress 2019 – Insights into paediatric bronchology Year: 2019 Non Invasive Ventilation in Acute Respiratory Failure in Patients of Post Tubercular Bronchiectasis: Effectiveness and Predictors of Failure. Source: International Congress 2017 – TB: co-morbidities and outcome Year: 2017 Prevalence of Eosinophilia in Patients with Tuberculosis Source: Virtual Congress 2021 – Epidemiology and burden of tuberculosis and other lung diseases Year: 2021 Allergy Testing in Asthmatics and Severe Asthmatics in Belgium : Role of Comorbidities Source: Virtual Congress 2020 – Asthma management: role of biomarkers and comorbidities Year: 2020 Low Level of  Airway Mucin 2 Predict Severe Exacerbations in Patients with Severe Chronic Obstructive Pulmonary Disease Source: International Congress 2017 – COPD biomarkers Year: 2017 Clinical characteristics and prognosis of chronic pulmonary aspergillosis Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014 Modes of Disease Progression in Different Forms of Interstitial Lung Disease with Usual Interstitial Pneumonia Histology in Patients with Idiopathic and Non-idiopathic Etiologies - A Single Center Experience Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside Year: 2019 Upper Respiratory Symptoms in Patients with Chronic Obstructive Pulmonary Disease Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD Year: 2020 Risk of Haemophilus Influenzae Infection in Patients with Chronic Obstructive Pulmonary Disease Using Inhaled Corticosteroids: A Cohort Study of 23,789 Outpatients. Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data Year: 2021 Prevalence and Characteristics of Patients Receiving Antifibrotic Therapy for Idiopathic Pulmonary Fibrosis Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries Year: 2020